Hoth Therapeutics Inc. (HOTH)
1.53
-0.02 (-1.29%)
At close: Jan 15, 2025, 3:59 PM
1.53
0.00%
After-hours Jan 15, 2025, 04:49 PM EST
undefined% (undefined)
| Bid | 1.52 |
| Market Cap | 10.56M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.27 |
| PE Ratio (ttm) | -1.2 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 1.53 |
| Volume | 1,275,021 |
| Avg. Volume (20D) | 9,094,796 |
| Open | 1.68 |
| Previous Close | 1.55 |
| Day's Range | 1.50 - 1.68 |
| 52-Week Range | 0.58 - 3.80 |
| Beta | undefined |
About HOTH
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment ...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 15, 2019
Employees 2
Stock Exchange NASDAQ
Ticker Symbol HOTH
Website https://www.hoththerapeutics.com
Analyst Forecast
According to 4 analyst ratings, the average rating for HOTH stock is "Buy." The 12-month stock price forecast is $4.5, which is an increase of 194.12% from the latest price.
Buy 50.00%
Hold 0.00%
Sell 0.00%
1 week ago ·
Source
+178.18%
Hoth Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago ·
Source
+1.05%
Hoth Therapeutics shares are trading higher after the company announced its board has approved the purchase of up to $1 million in Bitcoin.
